You are here: Industry Insights > Market News > Granules India gets board nod to raise foreign investment limit

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

water filter

WATER FILTER FOR WATER PURIFIER

DUST BAG

Small dust filter

HUMIDIFIER FILTER

Oil fume adsorption filter

Granules India gets board nod to raise foreign investment limit

financialexpressJuly 06, 2017

Tag: granules , foreign investment

Favorites

Granules India said its board has approved a proposal to increase the foreign investment limit in the company to 49 per cent.

The board of directors has agreed to increase the present limit of FII/ FPIs shareholding in the company to 49 per cent of the total paid-up equity share capital, Granules India said in a BSE filing.

However, it said, the decision would be subject to shareholders’ approval.

As on March 31, 2017, FPI holding in the company stood at 9.98 per cent. Other foreign nationals owned 0.06 per cent.

Previous:Zydus starts phase II trial of ZYAN1 for treating anaemia in patients with CKD

Next:Pain-free microneedle patch could help boost flu vaccination rates

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Granules India gets board nod to raise foreign investment limit | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Compound salvia miltiorrhiza granules (Containing extract of Salviae Miltiorrhizae Radix et Rhizoma

1-bromo-3-chloro-5,5-dimethylhydantoin Granules BCDMH CAS NO. 32718-18-6

1,3-dibromo-5,5-dimethylhydantoin DBDMH Granules CAS NO.77-48-5

lower price 97.5%~102.0% White to off-white,granules or powder Cefoxitin sodium

Azithromycin Granules 100mg, 250mg

Hot Melt Extruder Machine Twin Screw Plastic Granules Making Machine Double-sxrew Extruder Pharmaceu

Diminazene aceturate and Phenazone granules for injection

Naproxen Enteric_coated micro Granules Capsules

Diminazene aceturate and Phenazone and Vitamin B granules for injection

1,3-dichloro-5,5-dimethylhydantoin DCDMH Granules CAS 118-52-5

Granules India gets board nod to raise foreign investment limit

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>